- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.81 Å
- Oligo State
- homo-12-mer
- Ligands
- 12 x ZN: ZINC ION(Non-covalent)
- 12 x 01: (3~{Z})-3-(1~{H}-benzimidazol-5-ylmethylidene)-4-[(3~{R})-1-ethanoylpyrrolidin-3-yl]oxy-1~{H}-indol-2-one
01.2: 17 residues within 4Å:- Chain A: H.108, D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, S.291, F.293, W.297, H.298
- Chain E: P.230, N.231
- Ligands: ZN.1
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:W.175, A:F.293, A:W.297
- Hydrogen bonds: A:D.216
- pi-Stacking: A:W.175, A:F.293, A:W.297
01.4: 15 residues within 4Å:- Chain B: D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, F.293, W.297, H.298
- Chain D: P.230, N.231
- Ligands: ZN.3
7 PLIP interactions:7 interactions with chain B- Hydrophobic interactions: B:W.175, B:F.293, B:W.297
- Hydrogen bonds: B:D.216, B:Y.267
- pi-Stacking: B:W.175, B:W.297
01.6: 17 residues within 4Å:- Chain B: P.230, N.231
- Chain C: H.108, D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, S.291, F.293, W.297, H.298
- Ligands: ZN.5
6 PLIP interactions:5 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:I.271, C:W.297, B:P.230
- Hydrogen bonds: C:Y.267
- pi-Stacking: C:W.175, C:W.297
01.8: 16 residues within 4Å:- Chain C: F.228, P.230, N.231
- Chain D: H.108, D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, W.297, H.298
- Ligands: ZN.7
6 PLIP interactions:5 interactions with chain D, 1 interactions with chain C- Hydrophobic interactions: D:W.175, C:N.231
- Hydrogen bonds: D:D.216, D:Y.267
- pi-Stacking: D:W.175, D:W.297
01.10: 16 residues within 4Å:- Chain E: D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, F.293, W.297, H.298
- Chain K: P.230, N.231, Y.267
- Ligands: ZN.9
8 PLIP interactions:7 interactions with chain E, 1 interactions with chain K- Hydrophobic interactions: E:W.175, E:I.271, E:F.293, E:W.297, K:N.231
- Hydrogen bonds: E:Y.267
- pi-Stacking: E:W.175, E:W.297
01.12: 16 residues within 4Å:- Chain F: D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, F.293, W.297, H.298
- Chain I: F.228, P.230, N.231
- Ligands: ZN.11
8 PLIP interactions:8 interactions with chain F- Hydrophobic interactions: F:F.293, F:W.297
- Hydrogen bonds: F:D.216, F:Y.267
- pi-Stacking: F:W.175, F:W.175, F:F.293, F:W.297
01.14: 17 residues within 4Å:- Chain G: H.108, K.112, D.127, E.169, E.170, W.175, D.216, L.217, V.270, I.271, Q.272, W.297, H.298
- Chain J: F.228, F.229, N.231
- Ligands: ZN.13
9 PLIP interactions:8 interactions with chain G, 1 interactions with chain J- Hydrophobic interactions: G:W.175, G:I.271, G:I.271, J:N.231
- Hydrogen bonds: G:K.112, G:K.112, G:D.216
- pi-Stacking: G:W.175, G:W.297
01.16: 16 residues within 4Å:- Chain F: F.228, P.230, N.231
- Chain H: D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, F.293, W.297, H.298
- Ligands: ZN.15
11 PLIP interactions:9 interactions with chain H, 2 interactions with chain F- Hydrophobic interactions: H:I.271, H:F.293, H:W.297, F:P.230, F:N.231
- Hydrogen bonds: H:D.216, H:W.297
- pi-Stacking: H:W.175, H:F.293, H:W.297, H:W.297
01.18: 18 residues within 4Å:- Chain H: F.228, P.230, N.231
- Chain I: H.108, D.127, E.169, E.170, W.175, D.216, L.217, Y.267, V.270, I.271, Q.272, D.273, W.297, H.298
- Ligands: ZN.17
5 PLIP interactions:5 interactions with chain I- Hydrophobic interactions: I:W.175, I:W.175, I:W.175, I:W.297
- pi-Stacking: I:W.297
01.20: 18 residues within 4Å:- Chain J: H.108, D.127, E.169, E.170, W.175, D.216, L.217, Y.267, V.270, I.271, Q.272, D.273, W.297, H.298
- Chain L: F.228, P.230, N.231
- Ligands: ZN.19
7 PLIP interactions:5 interactions with chain J, 2 interactions with chain L- Hydrophobic interactions: J:W.175, J:W.297, L:P.230, L:N.231
- pi-Stacking: J:W.175, J:F.293, J:W.297
01.22: 14 residues within 4Å:- Chain A: F.228, P.230, N.231
- Chain K: H.108, D.127, E.169, E.170, W.175, D.216, Q.272, F.293, W.297, H.298
- Ligands: ZN.21
5 PLIP interactions:5 interactions with chain K- Hydrophobic interactions: K:W.175, K:F.293
- Hydrogen bonds: K:D.216
- pi-Stacking: K:W.175, K:W.297
01.24: 18 residues within 4Å:- Chain G: F.228, F.229, N.231, G.268, G.269
- Chain L: H.108, D.127, E.169, E.170, W.175, D.216, L.217, Y.267, I.271, Q.272, W.297, H.298
- Ligands: ZN.23
5 PLIP interactions:5 interactions with chain L- Hydrophobic interactions: L:W.297
- Hydrogen bonds: L:D.216
- pi-Stacking: L:W.175, L:F.293, L:W.297
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mou, J. et al., X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model. J.Med.Chem. (2024)
- Release Date
- 2024-06-12
- Peptides
- Glutaminyl-peptide cyclotransferase: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.81 Å
- Oligo State
- homo-12-mer
- Ligands
- 12 x ZN: ZINC ION(Non-covalent)
- 12 x 01: (3~{Z})-3-(1~{H}-benzimidazol-5-ylmethylidene)-4-[(3~{R})-1-ethanoylpyrrolidin-3-yl]oxy-1~{H}-indol-2-one
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Mou, J. et al., X-ray Structure-Guided Discovery of a Potent Benzimidazole Glutaminyl Cyclase Inhibitor That Shows Activity in a Parkinson's Disease Mouse Model. J.Med.Chem. (2024)
- Release Date
- 2024-06-12
- Peptides
- Glutaminyl-peptide cyclotransferase: ABCDEFGHIJKL
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
BB
AC
CD
DE
EF
FG
GH
HI
IJ
JK
KL
L